Țară: Israel
Limbă: ebraică
Sursă: Ministry of Health
NEISSERIA MENINGITIDES GROUP B STRAIN NZ98/254; NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN; NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN; NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN
GLAXO SMITH KLINE (ISRAEL) LTD
J07AH06
תרחיף להזרקה
NEISSERIA MENINGITIDES GROUP B STRAIN NZ98/254 25 MCG; NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN 50 MCG; NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN 50 MCG; NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN 50 MCG
תוך-שרירי
מרשם נדרש
GLAXO SMITHKLINE VACCINES S.R.L., ITALY
MENINGOCOCCUS B, OUTER MEMBRANE VESICLE VACCINE
החיסון יינתן לחולה הלוקה באחד מאלה:א. אספלניה, היפוספלניה אנטומית או תפקודית, נרכשת או מולדת.ב. חסר במערכת המשלים כגון חסר בפקטור D, פרופרידין ובמרכיב המשלים C5-9 או C3, לרבות מטופלים ב-Eculizumab או Ravulizumab.ג. נשאי HIV.
2021-02-28
" ) ( - 1986 ( 0.5 : ) " B : , 2 - " " 6 - " " . . . , . . . . 1 . ? ( Neisseria meningitides ) B . : B . ( Neisseria meningitides ) B . , .) ( ) ( . Recombinant Neisseria meningitidis group B NHBA fusion protein - 50 Recombinant Neisseria meningitidis group B NadA protein - 50 Recombinant Neisseria meningitidis group B fHbp fusion protein - 50 Outer membrane vesicles (OMV) from Neisseria meningitidis group B strain NZ98/254 measured as amount of total protein containing the PorA P1.4 - 25 2 . : • ( ) ( 6 ) . : • , . . , , , . • , . .) ( • , , . B , . • ( 28 ,) . , . • . , , . . , . . 50 . . ( HIV ,) . . , / , . , . , , : , b , , B , , , , , A , C , W , Y . . . , . . , , . . . , 4 " " . - 1 ( 23 " , ) " ." 3 . ? . . . ( 0.5 ) " , . . , . : 2 5 .) ( - . - . , - . , - 12 - 15 , 6 . , 24 . 6 11 6 11 ( .) - . - , . 12 23 12 23 ( .) - . - 12 23 . 2 10 2 10 . - . .) ( 11 ( 11 ) . - . .) ( 50 50 . . . . ! . . . , 4 . . , . . ( , ( ) : ) - , , / . , . ( 10 ) - - 1 10 : - ( 38 ) - - ( ) - - ( 12 23 ( ) ) - - - - ) ( - - - 1 10 : - ( 2 10 ) - 1 100 : - ( 40 ) - ) ( - - ) ( - 1 1000 : - , , , , . , , - , ( 11 ) - - 1 10 : - - - - - : . ( , , ,) , , . ,) ( , . . ( 11 ) . ( 11 .) , ( .) , ,) ( . . , . , " " ( www.health.gov.il " , ) : https://sideeffects.health.gov.il/ 5 . ? • ! . / . • ( exp. date ) . . • (2°C-8°C) . . • . • . . . 6 . • : Sucrose, sodium chloride, aluminium hydroxide, histidine and water for injections. • : . . . : . • ' , " ) ( : 25 . , • : GSK S.r.l , , . • : 155-59-34399 • , . . 2023 GSK . © 2023 GSK . The following information is intended for healthcare professionals only: Upon storage a fine off-white deposit may be observed in the pre-filled syringe containing the suspension. Before use, the pre-filled syringe should be well shaken in order to form a homogeneous suspension. The vaccine should be visually inspected for particulate matter and discoloration prior to administration. In the event of any foreign particulate matter and/or variation of physical aspect being Citiți documentul complet